Individual treatment-based precision medicine and syndrome differentiation treatment for integrative neurology

PAN Weidong

doi:10.12022/jnnr.2016-0047

PDF(1316 KB)

Journal of Neurology and Neurorehabilitation ›› 2016, Vol. 12 ›› Issue (2) : 57-63. DOI: 10.12022/jnnr.2016-0047

Editorial

Individual treatment-based precision medicine and syndrome differentiation treatment for integrative neurology

PAN Weidong

Author information +

History +

Abstract

With the publicity of the concept of precision medicine, some researchers or doctors have proposed that the precision medicine is the same as the concept of treatment based on syndrome differentiation of traditional Chinese medicine according to the same individual treatment methods. This paper summarizes what the individual treatment is and indicates the similarity and differentiation between the two concepts from microscopic and macroscopic points of view. Integrative neurology needs the dynamic integration of the two individual and precision methods. This integrated way may decrease the rates of misdiagnosis and therapeutic errors and improve the neurologic clinical effects.

Key words

Chinese and Western integrative neurology / Precision medicine / Syndrome differentiation treatment / Individual treatment

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

PAN Weidong. Individual treatment-based precision medicine and syndrome differentiation treatment for integrative neurology[J]. Journal of Neurology and Neurorehabilitation. 2016, 12(2): 57-63 https://doi.org/10.12022/jnnr.2016-0047

References

[1] COLLINS F S, VARMUS H. A new initiative on precision medicine[J]. N Engl J Med, 2015, 372(9):793-795.
[2] NISHI A, MILNER DA JR, GIOVANNUCCI E L, et al. Integration of molecular pathology, epidemiology and social science for global precision medicine[J]. Expert Rev Mol Diagn, 2016, 16(1):11-23.
[3] ZHOU L, WANG K, LI Q, et al. Clinical proteomics-drivenprecision medicine for targeted cancer therapy: current overview and futureperspectives[J]. Expert Rev Proteomics, 2016, 13(4):367-381.
[4] 李玉娟, 李连达, 李贻奎. 精准医疗与辨证施治[J]. 医学争鸣, 2016, 7(1):5-7.
[5] 郑昱. 中医的整体观、辨证论治原则与个体化用药[J]. 中国医药指南, 2011, 9(29):334-336.
[6] PAN W. Integrative reserve and integrative medicine[J]. Integr Med Int, 2014, 1(1):127-129.
[7] 蒋雨平, 王坚, 蒋雯巍. 新编神经疾病学[M]. 上海：上海科学普及出版社, 2015:1.
[8] 姜文斐, 汤雅馨, 潘卫东. 认知储备能与认知功能障碍的新进展[J]. 中国临床神经科学, 2016, 24(2):239-243.
[9] 卢全生, 雷燕, 陈可冀. AT_1R基因多态性与原发性高血压中医证型及降压中药疗效的关系[J]. 中国中西医结合杂志, 2005, 25(8):682-686.
[10] PANPALLI ATES M, KARAMAN Y, GUNTEKIN S, et al. Analysis of genetics andrisk factors of Alzheimer’s Disease[J]. Neuroscience, 2016, 325:124-131.
[11] IWAMI O, NIKI Y, WATANABE T, et al. Motor neuron disease on the Kii Peninsula of Japan: cycad exposure[J]. Neuroepidemiology, 1993, 12(6):307-312.
[12] MCMILLAN C T. Neurodegenerative disease: MRI biomarkers—a precision medicine tool in neurology?[J]. Nat Rev Neurol, 2016, 12(6):323-324.
[13] 潘卫东. 结合医学与中西医结合神经病学[J]. 神经病学与神经康复学杂志, 2016, 12(1):8-11.
[14] CHEN X, PAN W. The treatment strategies for neurodegenerative diseases by integrative medicine[J]. Integr Med Int, 2014(1):223-225.
[15] 陈可冀. 病证结合治疗观与临床实践[J]. 中国中西医结合杂志, 2011, 31(8):1016-1017.
[16] TAN L, JIANG T, TAN L, et al. Toward precision medicine in neurologicaldiseases[J]. Ann Transl Med, 2016, 4(6):104.
[17] ARONSON N. Making personalized medicine more affordable[J]. Ann N Y Acad Sci, 2015, 1346(1):81-89.
[18] 于军. “人类基因组计划”回顾与展望：从基因组生物学到精准医学[J]. 自然杂志, 2013, 35(5):326-331.
[19] 徐速, 李维. 精准医学研究热点的双向聚类计量分析[J]. 医学与哲学（B）, 2015, 36(6B):1-5.